Skip to main content
SpringerLink
Log in

Enteral Antimicrobials

  • Chapter
Infection Control in the Intensive Care Unit

Part of the book series: Topics in Anaesthesia and Critical Care ((TIACC))

Conclusions

SDD using enteral antimicrobials is now an evidence-based protocol. It is the best-ever evaluated intervention in intensive care medicine that reduces infectious morbidity and mortality. It is a cheap maneuver without side effects in terms of emergence of resistance. In ICUs using enteral antimicrobials, gut carriage of potential pathogens, both sensitive and resistant, is significantly reduced.However, hand disinfecting as a general hygiene procedure is still valuable and can be expected to be more effective in ICUs where all long-stay patients are successfully decontaminated, free from overgrowth of AGNB, yeasts, and S. aureus, thus subsequently reducing hand contamination and, consequently, the chance of transmission. SDD is the gold standard with which new maneuvers of infection control should be compared.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. van Saene HKF, Taylor N, Donnell SC et al (2003) Gut overgrowth with abnormal flora: the missing link in parenteral nutrition-related sepsis in surgical neonates. Eur J Clin Nutr 57:548–553

    Article  PubMed  Google Scholar 

  2. Husebye H (1995) Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med 237: 419–427

    Article  PubMed  CAS  Google Scholar 

  3. Marshall JC, Christou NV, Meakins JL (1988) Small bowel overgrowth and systemic immuno-suppression in experimental peritonitis. Surgery 104:404–411

    PubMed  CAS  Google Scholar 

  4. Ketai LH, Rypka G (1993) The course of nosocomial oropharyngeal colonisation in patients recovering from acute respiratory failure. Chest 103:1837–1841

    PubMed  CAS  Google Scholar 

  5. Alcock SR (1990) Short-term parenteral antibiotics used as supplement to SDD regimens. Infection 18[Suppl 1]:514–518

    Google Scholar 

  6. Sompolinsky D, Yaron V, Alkan WJ (1967) Microbiological changes in the human faecal flora following the administration of tetracyclines and chloramphericol. Am J Proctol 18:471–478

    PubMed  CAS  Google Scholar 

  7. Garbino T, Lew DP, Romand JA et al (2002) Prevention of severe Candida infections in non-neutropenic, high risk, critically ill patients: a randomised, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708–1717

    Article  PubMed  Google Scholar 

  8. Chang FY, Peacock JE, Musher MM et al (2003) Staphylococcus aureus bacteremia. Recurrence and the impact of antibiotic treatment in a prospective multicentre study. Medicine (Baltimore) 82:333–339

    Article  PubMed  CAS  Google Scholar 

  9. van Saene R, Fairclough S, Petros A (1998) Broad and narrow spectrum antibiotics: a different approach. Clin Microbiol Infect 4:56–57

    PubMed  Google Scholar 

  10. Geraci JE, Heilman FR, Nicols DR et al (1956) Some laboratory and clinical experience with a new antibiotic, vancomycin. Proc Staff Meet Mayo Clin 31:564–582

    CAS  PubMed  Google Scholar 

  11. Tedesco F, Markham R, Gurwith M et al (1978) Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet II:226–228

    Article  Google Scholar 

  12. D’Agata EMC, Venkataraman L, De Girolami P et al (1999) Colonisation with broadspectrum cephalosporin-resistant Gram-negative bacilli in intensive care units during a non-outbreak period: prevalence, risk factors and rate of infection. Crit Care Med 27:1090–1095

    Article  PubMed  CAS  Google Scholar 

  13. Petros AJ, O’Connell M, Roberts C et al (2001) Systemic antibiotics fail to clear multi drug-resistant Klebsiella from a paediatric ICU. Chest 119:862–866

    Article  PubMed  CAS  Google Scholar 

  14. Jonge EJ de, Schultz M, Spanjaard L et al (2003) Effects of selective decontamination of the digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised, controlled trial. Lancet 362:1011–1016

    Article  PubMed  CAS  Google Scholar 

  15. Corbella X, Montero A, Pujol M et al (2000) Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multi-resistant Acinetobacter baumannii. J Clin Microbiol 38:4086–4095

    PubMed  CAS  Google Scholar 

  16. Toltzis PH, Yamashita T, Vilt L et al (1998) Antibiotic restriction does not alter endemic colonization with resistant Gram-negative rods on a paediatric intensive care unit. Crit Care Med 26:1893–1899

    PubMed  CAS  Google Scholar 

  17. van Saene HKF, Petros AJ, Ramsay G, Baxby D (2003) All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med 29:677–690

    PubMed  Google Scholar 

  18. Yao YM, Lu LR, Yu Y et al (1997) Influence of selective decontamination of the digestive tract on cell-mediated immune function and bacteria/endotoxin translocation in thermally injured rats. J Trauma 42:1073–1079

    PubMed  CAS  Google Scholar 

  19. Baxby D, van Saene HKF, Stoutenbeek CP, Zandstra DF (1996) Selective decontamination of the digestive tract: 13 years on,what it is and what it is not. Intensive Care Med 22:699–706

    PubMed  CAS  Google Scholar 

  20. van der Waaij D (1992) History of recognition and measurement of colonisation resistance of the digestive tract as an introduction to selective gastro-intestinal decontamination. Epidemiol Infect 109:315–326

    Article  PubMed  Google Scholar 

  21. Bodey GP (1981) Antibiotic prophylaxis in cancer patients: regimens of oral, nonabsorbable antibiotics for prevention of infection during induction of remission. Rev Infect Dis 3:S259–S268

    PubMed  Google Scholar 

  22. van Saene HKF, Stoutenbeek CP (1987) Selective decontamination. J Antimicrob Chemother 20: 462–465

    PubMed  Google Scholar 

  23. Harris JC, Dupont HL, Hornick RB (1972) Faecal leucocytes in diarrheal illness. Ann Intern Med 76: 697–703

    PubMed  CAS  Google Scholar 

  24. Stoutenbeek CP (1989) Topical antibiotic regimen. In: van Saene HKF, Stoutenbeek CP, Lawin P, Ledingham IM (eds) Infection control by selective decontamination. Springer Verlag, Berlin Heidelberg New York, pp 95–101

    Google Scholar 

  25. van Saene JJM, van Saene HKF, Tarko-Smith NJ, Beukeveld GJ (1988) Enterobacteriaceae suppression by three different oral doses of polymyxin E in human volunteers. Epidemiol Infect 100:407–417

    PubMed  Google Scholar 

  26. Sogaard H (1982) The pharmacodynamics of polymyxin antibiotics with special reference to drug resistance liability. J Vet Pharmacol Ther 5:219–281

    PubMed  CAS  Google Scholar 

  27. Danner RL, Joiner KA, Rubin MR et al (1989) Purification, toxicity and anti-endotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother 33:1428–1432

    PubMed  CAS  Google Scholar 

  28. Veringa EM, van der Waaij D (1984) Biological inactivation by faeces of anti-microbial drugs applicable in selective decontamination of the digestive tract. J Antimicrob Chemother 14:605–612

    PubMed  CAS  Google Scholar 

  29. van Saene JJM, van Saene HKF, Stoutenbeek CP, Lerk CF (1985) Influence of faeces on the activity of anti-microbial agents used for decontamination of the alimentary canal. Scand J Infect Dis 17:295–300

    PubMed  Google Scholar 

  30. Hazenberg MP, Pennock-Schroder AM, van de Merwe JP (1985) Binding to and bacterial effect of aztreonam, temocillin, gentamicin and tobramycin on human faeces. J Hyg 95:255–263

    CAS  Google Scholar 

  31. Mulder JG, Wiersma WE, Welling GW, van der Waaij D (1984) Low dose oral tobramycin treatment for selective decontamination of the digestive tract: a study in human volunteers. J Antimicrob Chemother 13:495–504

    PubMed  CAS  Google Scholar 

  32. Cavaliere F, Sciarra M, Crociani E et al (1988) Tobramycin serum levels during selective decontamination of the gastro-intestinal tract. Minerva Anestesiol 54:233–226

    Google Scholar 

  33. Zobel G, Kuttnig M, Grubbauer HM et al (1991) Reduction of colonisation and infection rate during paediatric intensive care by selective decontamination of the digestive tract. Crit Care Med 19:1242–1246

    PubMed  CAS  Google Scholar 

  34. Gaussorgues P, Salord F, Sirodot M et al (1991) Nosocomial bacteremia in patients under mechanical ventilation and receiving beta-inotropic drugs; efficacy of digestive decontamination. Rean Soins Intens Med Urg 7: 169–174

    Google Scholar 

  35. Smith CA, Baker EN (2002) Aminoglycoside antibiotic resistance of enzymatic deactivation. Curr Drug Targets Infect Disord 2:143–160

    Article  PubMed  CAS  Google Scholar 

  36. Sjolin T, Goscinski G, Lundholm M et al (2000) Endotoxin release from Escherichia coli after exposure to tobramycin: dose dependency and reduction in cefuroxime-induced endotoxin release. Clin Microbiol Infect 6: 74–81

    Article  PubMed  CAS  Google Scholar 

  37. Vandenbossche H, Dromer F, Improvisi I et al (1998) Antifungal drug resistance in pathogenic fungi. Med Mycol 36:119–128

    Article  CAS  Google Scholar 

  38. Hofstra W, deVries-Hospers HG, van der Waaij D (1979) Concentrations of nystatin in faeces after oral administration of various doses of nystatin. Infection 7:166–170

    Article  PubMed  CAS  Google Scholar 

  39. Hofstra W, de Vries-Hospers HG, der Waaij D van (1982) Concentrations of amphotericin B in faeces and blood of healthy volunteers after oral administration of various doses. Infection 10:233–277

    Article  Google Scholar 

  40. Silvestri L, Milanese M, Oblach L et al (2002) Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 30:391–399

    Article  PubMed  Google Scholar 

  41. Silvestri L, Milanese M, Gregori D, van Saene HKF (2005) Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomised controlled trials. Intensive Care Med (in press)

    Google Scholar 

  42. Bergmans DCJJ, Bonten MJM, Gaillard CA et al (2001) Prevention of ventilator-associated pneumonia by oral decontamination. Am J Respir Crit Care Med 164:382–388

    PubMed  CAS  Google Scholar 

  43. Korinek AM, Laisne MJ, Nicolas MH et al (1993) Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomised, placebo-controlled study. Crit Care Med 21:1466–1473

    PubMed  CAS  Google Scholar 

  44. Krueger WA, Lenhart FP, Neeser G et al (2002) Influence of combined intravenous and topical antibiotic prophylaxis in the incidence of infections, organ dysfunctions and mortality in critically ill surgical patients. Am J Respir Crit Care Med 166:1029–1037

    Article  PubMed  Google Scholar 

  45. Pugin J, Auckenthaler R, Lew DP, Suter PM (1991) Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. JAMA 265:2704–2710

    Article  PubMed  CAS  Google Scholar 

  46. Schardey HM, Joosten U, Finke U et al (1997) The prevention of anastomotic leakage after total gastrectomy with local decontamination. Ann Surg 225:172–180

    Article  PubMed  CAS  Google Scholar 

  47. Silvestri L, van Saene HKF, Milanese M et al (2004) Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 23:921–926

    PubMed  CAS  Google Scholar 

  48. Bodey GP, Pan T (1980) Absorption of tobramycin after chronic oral administration. Curr Ther Res 28: 394–401

    Google Scholar 

  49. Gotoff SP, Lepper MH (1965) Treatment of Salmonella carriers with colistin sulfate. Am J Med Sci 249:399–403

    PubMed  CAS  Google Scholar 

  50. Misset B, Kitzis MD, Conscience G et al (1994) Mechanisms of failure to decontaminate the gut with polymyxin E, gentamicin and amphotericin B in patients in intensive care. Eur J Clin Microbiol Infect Dis 13:165–170

    Article  PubMed  CAS  Google Scholar 

  51. Stoutenbeek CP, van Saene HKF (1990) Infection prevention in intensive care by selective decontamination of the digestive tract. J Crit Care 5:137–156

    Article  Google Scholar 

  52. Krueger WA, Ruckdeschel G, Unertl K (1999) Elimination of faecal Enterobacteriaceae by intravenous ciprofloxacin is not inhibited by concomitant sucralfate, a microbiological and pharmacokinetic study on patients. Infection 6:335–340

    Article  Google Scholar 

  53. Daneshmend TK, Warnock DW (1983) Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet 8:17–42

    PubMed  CAS  Google Scholar 

  54. Winter R, Humphreys H, Pick A et al (1992) A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. J Antimicrob Chemother 30:73–87

    PubMed  CAS  Google Scholar 

  55. Stoutenbeek CP, Saene HKF van, Zandstra DF (1987) The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother 19:513–520

    PubMed  CAS  Google Scholar 

  56. D’Amico R, Pifferi S, Leonetti C et al (1998) Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 316:1275–1285

    PubMed  CAS  Google Scholar 

  57. Liberati A, D’Amico R, Pifferi S et al (2004) Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care [Cochrane Review]. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd

    Google Scholar 

  58. van Saene HKF, Stoutenbeek CP, Faber-Nijholt R, van Saene JJM (1992) Selective decontamination of the digestive tract contributes to the control of disseminated intravascular coagulation in severe liver impairment. J Pediatr Gastroenterol Nutr 14:436–442

    Article  PubMed  Google Scholar 

  59. Fink MP, Mythen MG (1999) The role of gut-derived endotoxin in the pathogenesis of multiple organ dysfunction. In: Brade H, Opal SM, Vogel SN, Morrison DC (eds) Endotoxin in health and disease. Dekker, New York, pp 855–864

    Google Scholar 

  60. Cohen J (2000) The detection and interpretation of endotoxaemia. Intensive Care Med 26:S51–S56

    Article  PubMed  Google Scholar 

  61. van Saene JJM, Stoutenbeek CP, van Saene HKF et al (1996) Reduction of the intestinal endotoxin pool by three different SDD regimens in human volunteers. J Endotoxin Res 3:337–343

    Google Scholar 

  62. Martinez-Pellus AE, Merino P, Bru M et al (1993) Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 21:1684–1689

    PubMed  CAS  Google Scholar 

  63. Martinez-Pellus AE, Merino P, Bru M et al (1997) Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Intensive Care Med 23:1251–1257

    Article  PubMed  CAS  Google Scholar 

  64. Bouter H, Schippers EF, Luelmo SAC et al (2002) No effect of pre-operative selective gut decontamination on endotoxemia and cytokine activation during cardio-pulmonary bypass: a randomised, placebo-controlled study. Crit Care Med 30:38–43

    Article  PubMed  CAS  Google Scholar 

  65. Bion JF, Badger I, Crosby HA et al (1994) Selective decontamination of the digestive tract reduces Gram-negative pulmonary colonisation but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med 22:40–49

    PubMed  CAS  Google Scholar 

  66. Maring JK, Zwaveling JH, Klompmaker IJ et al (2002) Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post-operative morbidity. Transpl Int 15:329–334

    Article  PubMed  Google Scholar 

  67. Oudemans-van Straaten HM, vanSaene HKF, Zandstra DF (2003) Selective decontamination of the digestive tract: use of the correct antibiotics is crucial. Crit Care Med 31:334–335

    Article  Google Scholar 

  68. Schippers EF, van Dissel JT (2003) Selective gut decontamination. Crit Care Med 31:2715–2716

    Article  PubMed  CAS  Google Scholar 

  69. van Saene HKF, Silvestri L, Bams JL et al (2003) Selective decontamination of the digestive tract: use in liver transplantation is evidence-based. Crit Care Med 31:1600–1601

    Article  PubMed  Google Scholar 

  70. Hammond JMJ, Potgieter PD (1995) Long term effects of selective decontamination on anti-microbial resistance. Crit Care Med 23:637–645

    Article  PubMed  CAS  Google Scholar 

  71. Leone M, Albanese J, Antonini F et al (2003) Long term (6-year) effect of selective digestive decontamination on anti-microbial resistance in intensive care, multiple-trauma patients. Crit Care Med 31:2090–2095

    Article  PubMed  Google Scholar 

  72. Tetteroo GWM, Wagenvoort JHT, Bruining HA (1994) Bacteriology of selective decontamination: efficacy and rebound colonisation. J Antimicrob Chemother 34:139–148

    PubMed  CAS  Google Scholar 

  73. Saunders N, Hammond JMJ, Potgieter PD et al (1994) Mirobiological surveillance during selective decontamination of the digestive tract [SDD]. J Antimicrob Chemother 34:529–544

    PubMed  CAS  Google Scholar 

  74. Gastinne H, Wolff M, Delatour F et al (1992) A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. The French study group on selective decontamination of the digestive tract. N Engl J Med 326:594–599

    Article  PubMed  CAS  Google Scholar 

  75. Hammond JMJ, Potgieter PD, Saunders GL et al (1992) Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 340:5–9

    Article  PubMed  CAS  Google Scholar 

  76. Ferrer M, Torres A, Gonzales J et al (1994) Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 120:389–395

    PubMed  CAS  Google Scholar 

  77. Wiener J, Itokazu G, Nathan C et al (1995) A randomised, double-blind, placebo-controlled trial of selective decontamination in a medical, surgical intensive care unit. Clin Infect Dis 20:861–867

    PubMed  CAS  Google Scholar 

  78. Lingnau W, Berger J, Javorsky F et al (1997) Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 42:687–694

    Article  PubMed  CAS  Google Scholar 

  79. Verwaest C, Verhaegen J, Ferdinande P et al (1997) Randomised, controlled trial of selective decontamination in 600 mechanically ventilated patients in a multi-disciplinary intensive care unit. Crit Care Med 25:63–71

    Article  PubMed  CAS  Google Scholar 

  80. Sanchez Garcia M, Cambronero Galache JA, Lopez Diaz J et al (1998) Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. Am J Respir Crit Care Med 158: 908–916

    PubMed  CAS  Google Scholar 

  81. de la Cal MA, Cerda E, van Saene HKF et al (2004) Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 56:175–183

    Article  PubMed  Google Scholar 

  82. van Saene HKF, Weir WI, de la Cal MA et al (2004) MRSA-time for a more pragmatic approach? J Hosp Infect 56:170–174

    Article  PubMed  Google Scholar 

  83. White A (1961) Relation between quantitative nasal cultures and dissemination of staphylococci. J Lab Clin Med 58:273–277

    PubMed  CAS  Google Scholar 

  84. Brodie J, Kerr MR, Sommerville T (1956) The hospital staphylococcus. A comparison of nasal and faecal carrier states. Lancet I:19–20

    Article  Google Scholar 

  85. Greendyke RM, Constantine HP, Magruder GB et al (1958) Staphylococci on a medical ward, with special reference to faecal carriers. Am J Clin Pathol 30:318–322

    PubMed  CAS  Google Scholar 

  86. Hone R, Keane CT, Fitzpatrick S (1974) Faecal carriage of Staphylococcus aureus in infantile enteritis due to enteropathic Escherichia coli. Scand J Infect Dis 6:329–332

    PubMed  CAS  Google Scholar 

  87. Brady LM, Thomson M, Palmer MA et al (1990) Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Aust 152:240–245

    PubMed  CAS  Google Scholar 

  88. Salzman TC, Clark JJ, Klemm L (1967) Hand contamination of personnel as a mechanism of cross-infection in nosocomial infections with antibiotic-resistant Escherichia coli and Klebsiella Aerobacter. Antimicrob Agents Chemother 7:97–100

    CAS  PubMed  Google Scholar 

  89. Nystrom B (1983) Optimal design/personnel for control of intensive care unit infection. Infect Control 4:388–390

    PubMed  CAS  Google Scholar 

  90. Crossley K, Landesmann B, Zaske D (1979) An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. II. Epidemiology studies. J Infect Dis 139: 280–287

    PubMed  CAS  Google Scholar 

  91. Viviani M, van Saene HKF, Dezzoni R et al (2005) Control of imported and acquired methicillin-resistant Staphylococcus aureus [MRSA] in mechanically ventilated patients: a dose-response study of oral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care (in press)

    Google Scholar 

  92. Bonten MJM, Gaillard CA, Johanson WG et al (1994) Colonization in patients receiving and not receiving topical antimicrobial prophylaxis. Am J Respir Crit Care Med 150:1332–1340

    PubMed  CAS  Google Scholar 

  93. Brun-Buisson C, Legrand P, Rauss A et al (1989) Intestinal decontamination for control of nosocomial multi-resistant Gram-negative bacilli: study of an outbreak in an intensive care unit. Ann Intern Med 110: 873–881

    PubMed  CAS  Google Scholar 

  94. Taylor ME, Oppenheim BA (1991) Selective decontamination of the gastro-intestinal tract as an infection control measure. J Hosp Infect 17:271–278

    Article  PubMed  CAS  Google Scholar 

  95. Damjanovic V, Connolly CM, van Saene HKF et al (1993) Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect 24:245–259

    Article  PubMed  CAS  Google Scholar 

  96. Rice LB (2001) Emergence of vancomycin-resistant enterococci. Emerg Infect Dis 7:183–187

    Article  PubMed  CAS  Google Scholar 

  97. Sanchez M, Mir N, Canton R et al (1997) The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant Staphyloccocus aureus in critically ill patients. A double-blind, randomized, placebo-controlled study (abstract). Abstracts of the 37th ICAAC, Toronto Canada, p 310

    Google Scholar 

  98. Stiefel U, Paterson DL, Pultz NJ et al (2004) Effect of increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centres. Infect Control Hosp Epidemiol 25:380–383

    Article  PubMed  Google Scholar 

  99. Salgado CD, Giannetta ET, Farr BM (2004) Failure to develop vancomycin-resisteant Enterococcus with oral treatment of Clostridium difficile. Infect Control Hosp Epidemiol 25:413–417

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, University Hospital of Principe de Asturias, Madrid, Spain

    M. Sanchez

  2. Department of Oncology, Alder Hey Children’s Hospital, NHS Trust, Liverpool, UK

    B.P. Pizer

  3. Department of Bacteriology, Western Infirmary Glasgow, Glasgow, UK

    S.R. Alcock

Authors
  1. M. Sanchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B.P. Pizer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S.R. Alcock
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Microbiology, University of Liverpool Alder Hey Children’s Hospital, NHS Trust, Liverpool, UK

    H. K. F. van Saene M.D.

  2. Department of Critical Care Medicine, University Hospital of Getafe, Madrid, Spain

    M. A. De La Cal M.D.

  3. Emergency Department and Unit of Anesthesia and Intensive Care, Presidio Ospedaliero of Gorizia, Gorizia, Italy

    L. Silvestri M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Italia

About this chapter

Cite this chapter

Sanchez, M., Pizer, B., Alcock, S. (2005). Enteral Antimicrobials. In: van Saene, H.K.F., De La Cal, M.A., Silvestri, L. (eds) Infection Control in the Intensive Care Unit. Topics in Anaesthesia and Critical Care. Springer, Milano . https://doi.org/10.1007/88-470-0361-X_9

Download citation

  • DOI: https://doi.org/10.1007/88-470-0361-X_9

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0185-5

  • Online ISBN: 978-88-470-0361-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation